[Federal Register Volume 71, Number 101 (Thursday, May 25, 2006)]
[Notices]
[Page 30166]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-7977]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on February 22, 2006, Lilly Del 
Caribe, Inc., Chemical Plant, Kilometer 146.7, State Road 2, Mayaguez, 
Puerto Rico 00680, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of 
Dextropropoxyphen (9273), a basic class of controlled substance listed 
in Schedule II.
    The company plans to manufacture the listed controlled substances 
in bulk for distribution to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such written comments or objections being sent via regular mail 
may be addressed, in quintuplicate, to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration, Washington, DC 20537, Attention: DEA Federal Register 
Representative, Liaison and Policy Section (ODL); or any being sent via 
express mail should be sent to DEA Headquarters, Attention: DEA Federal 
RegisterRepresentative/ODL, 2401 Jefferson-Davis Highway, Alexandria, 
Virginia 22301; and must be filed no later than July 24, 2006.

    Dated: May 17, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E6-7977 Filed 5-24-06; 8:45 am]
BILLING CODE 4410-09-P